[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613779":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":49,"centralContacts":53,"locations":59,"responsibleParty":77,"collaborators":36,"id":79,"slug":80,"hasResults":81,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":36,"eligibilityCriteria":85,"healthyVolunteers":86,"sex":87,"minAge":88,"maxAge":89,"enrollmentInfo":90,"targetDuration":36,"studyType":93,"phases":94,"briefSummary":96,"conditions":97,"keywords":36,"overallStatus":62,"whyStopped":36,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":111},{"fullName":5,"class":6},"London Metropolitan University","OTHER",[8,14,19,24],{"label":9,"type":10,"description":11,"interventionNames":12},"Cannabidiol 30mg","EXPERIMENTAL","This will be a dose specific suppository of 30mg, which will be used for one month. Frequency will depend on how often the participant engages in sexual intimacy.",[13],"Dietary Supplement: Cannabidiol suppository intervention 1",{"label":15,"type":10,"description":16,"interventionNames":17},"Cannabidiol 50mg","This will be a dose specific suppository of 50mg, which will be used for one month. Frequency will depend on how often the participant engages in sexual intimacy.",[18],"Dietary Supplement: Cannabidiol suppository intervention 2",{"label":20,"type":10,"description":21,"interventionNames":22},"Cannabidiol 100mg","This will be a dose specific suppository of 100mg, which will be used for one month. Frequency will depend on how often the participant engages in sexual intimacy.",[23],"Dietary Supplement: Cannabidiol suppository intervention 3",{"label":25,"type":26,"description":27,"interventionNames":28},"Care as usual","ACTIVE_COMPARATOR","This is the care as usual group, which will be the control for comparative outcomes with sexual function, sexual pain, well being and quality of life.",[29],"Other: Non cannabidiol group control",[31,37,41,45],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"DIETARY_SUPPLEMENT","Cannabidiol suppository intervention 1","Cannabidiol suppository dose specific 30mg",[9],null,{"type":32,"name":38,"description":39,"armGroupLabels":40,"otherNames":36},"Cannabidiol suppository intervention 2","Cannabidiol suppository dose specific 50mg",[15],{"type":32,"name":42,"description":43,"armGroupLabels":44,"otherNames":36},"Cannabidiol suppository intervention 3","Cannabidiol suppository dose specific 100mg",[20],{"type":6,"name":46,"description":47,"armGroupLabels":48,"otherNames":36},"Non cannabidiol group control","Care as usual group",[25],[50],{"name":51,"affiliation":5,"role":52},"Samantha Banbury","PRINCIPAL_INVESTIGATOR",[54],{"name":55,"role":56,"phone":57,"phoneExt":36,"email":58},"Anna Kamyk","CONTACT","02074230000","rpo@londonmet.ac.uk",[60],{"facility":61,"status":62,"city":63,"state":36,"zip":64,"country":65,"countryCode":66,"cosmosGeoPoint":67,"geoPoint":72,"contacts":73},"School of Social Sciences and Professions","RECRUITING","London","N7 8DB","United Kingdom","UK",{"type":68,"coordinates":69},"Point",[70,71],-0.12574,51.50853,{"lat":71,"lon":70},[74],{"name":75,"role":56,"phone":36,"phoneExt":36,"email":76},"Samantha Banbury, PhD","s.banbury1@londonmet.ac.uk",{"type":78,"investigatorFullName":36,"investigatorTitle":36,"investigatorAffiliation":36,"oldNameTitle":36,"oldOrganization":36},"SPONSOR","100613779","the-use-of-cannabidiol-suppositories-for-sexual-pain-100613779",false,"NCT07271030","The Use of Cannabidiol Suppositories for Sexual Pain","The Use of Cannabidiol Suppositories for Sexual Pain: A Randomised Controlled Study","Inclusion Criteria:\n\n* Has previously used cannabidiol in any capacity and has not experienced any allergic reaction\n* Is experiencing sexual pain\n* There will be an absence of co occurring difficulties\n* Has attempted sexual intercourse in the last month\n* Age 18 years or older\n* Read and write English\n* Patient Health Questionnaire 9 screening score range between 0-9 mild\n* General Anxiety Disorder 7 screening score range between 0-9 mild\n* There are no restrictions on sex, gender, sexuality, or disability\n\nExclusion Criteria:\n\nHas experienced an allergic reaction to cannabidiol in any capacity\n\n* Has not attempted sexual intercourse in the last month\n* Has co occurring difficulties\n* Aged below 18 years old\n* Are not experiencing sexual pain\n* Patient Health Questionnaire 9 screening score range between moderate to severe - 10-27\n* General Anxiety Disorder 7 screening score range between 10- 21.",true,"ALL","18 Years","100 Years",{"count":91,"type":92},50,"ESTIMATED","INTERVENTIONAL",[95],"NA","Research aim: To determine how cannabidiol suppositories might reduce sexual pain during intimacy. Outcomes are also hoped to increase sexual functioning, well-being, and quality of life.\n\nResearch intention: If cannabidiol suppository intervention reduces sexual pain and increases general well-being, then this research would be repeated on a larger scale, targeting psychosexual services.\n\nA brief overview of the intervention:\n\nQuantitatively, randomisation of cannabidiol suppositories will be into dose-specific groups. The intervention will be delivered over a period of one month, with follow-up scheduled at 12 weeks. Qualitatively, participants were asked approximately eight open-ended feedback questions throughout the study.",[98,99,100,101],"Well-Being, Psychological","Quality of Life","Sexual Behavior","Sexual Pain Disorder","2026-01-23",{"date":104,"type":105},"2026-01-26","ACTUAL",{"date":107,"type":105},"2026-01-16",{"date":109,"type":92},"2026-08",{"name":5,"class":6},1]